kidney stones and semaglutide significantly reduces risk of major disease events, cardiovascular outcomes mortality in patients with type 2 diabetes and chronic kidney disease Semaglutide: A Breakthrough for Chronic

The 10 mg/day arm produced a smaller result than the 1 mg arm, not a larger one

Ozempic is strictly for diabetes management, while Wegovy is optimized for weight loss

This study analyzed the information from the SELECT study, and found that this benefit to cardiovascular health did not depend on how overweight patients were or how much weight they lost. This interesting finding suggests that the cardiovascular benefits of semaglutide act through a biochemical mechanism not dependent simply on changing the body weight of an individual, he continued

Other weight loss medications such as Wegovy or Saxenda may be covered in your state